@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-PLJV5R12-5 mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-L0W912R9-T mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-XWGWH230-B mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-X079LVDZ-K
  skos:prefLabel "Miotics"@en, "Myotiques"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-JHRKFGLJ-J .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-L5LZJ1HF-F mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-B7NSWL3W-0 mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-RT3QLV95-9 mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-HVPDJNXG-V mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-S6HMPW8W-6 mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-KDZD7M9K-G mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-SBZ9GPM9-X mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W5VM5WHJ-C
  skos:prefLabel "Sympathetic Nervous System"@en, "Système nerveux sympathique"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-JHRKFGLJ-J .

jvr:-LT2CD96R-8 mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-JHRKFGLJ-J
  skos:prefLabel "Sympatholytiques"@fr, "Sympatholytics"@en ;
  a mesh:Descriptor, skos:Concept ;
  mesh:allowableQualifier jvr:-NHL3D2X0-S, jvr:-Q3979798-W, jvr:-H7K65Q8S-Z, jvr:-W6SQV79N-S, jvr:-D0F21513-5, jvr:-NB0XHT3S-N, jvr:-BT300B3G-Q, jvr:-HQRFT0C6-B, jvr:-WK5F724J-1, jvr:-T9HQD7ST-J, jvr:-TJHVZCRZ-0, jvr:-R3QWLHRG-V, jvr:-M63HSDM7-1, jvr:-G30ZJ446-J, jvr:-FWD2BGQ0-9, jvr:-XV06LPML-W, jvr:-SBNWSM1T-R, jvr:-THHNVC7V-3, jvr:-L6C0XPHT-4, jvr:-S0CS1X5R-5, jvr:-CB30NGKB-3, jvr:-R0ZCQ8X6-J, jvr:-NFTHND7Q-8, jvr:-NKM836P1-M ;
  dc:created "1999-01-01"^^xsd:date ;
  skos:altLabel "Sympatholytic Agents"@en, "Sympatholytic Agent"@en, "Sympatholytic Drugs"@en, "Sympatholytic"@en, "Sympathetic-Blocking Agents"@en, "Sympatholytic Drug"@en, "Médicaments sympatholytiques"@fr, "Agents sympatholytiques"@fr ;
  skos:broader jvr:-FQBBBDKB-X ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D013565> ;
  dc:modified "2021-06-30"^^xsd:date ;
  skos:definition "Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here."@en ;
  skos:related jvr:-JG5CGZN8-C, jvr:-X079LVDZ-K, jvr:-ZHSSZXQ2-N, jvr:-W5VM5WHJ-C ;
  skos:hiddenLabel "Sympatholytic Effects"@en, "Sympatholytic Effect"@en ;
  dc:established "1960-01-01"^^xsd:date ;
  skos:inScheme jvr: .

jvr:-GVDJ9CKK-Q mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr: a skos:ConceptScheme .
jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-F265LGNK-T mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-F108GX7C-2 mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-JG5CGZN8-C
  skos:prefLabel "Agents adrénergiques"@fr, "Adrenergic Agents"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-JHRKFGLJ-J .

jvr:-HC985P3V-V mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NLST8VS4-S mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-ZHSSZXQ2-N
  skos:prefLabel "Antagonistes adrénergiques"@fr, "Adrenergic Antagonists"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-JHRKFGLJ-J .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H3T94D57-H mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-XKQFRDGH-H mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-FQBBBDKB-X
  skos:prefLabel "Agents du système nerveux autonome"@fr, "Autonomic Agents"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-JHRKFGLJ-J .

jvr:-GTJV37K0-2 mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FQ8R4W70-G mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-BFM7DX77-4 mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-LRJ3FXGW-C mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .
jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-LVWWQ2CS-N mesh:pharmacologicalAction jvr:-JHRKFGLJ-J .